Suchergebnisse - "Schmidt, Peter C"

PubPharm (3)

1

Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints : Design Implications for Future Trials

enthalten in: Headache | 2019

von Hindiyeh, N. | Kellerman, D. | Schmidt, P.

ErratumIn: Headache. 2019 Sep;59(8):1427. - PMID 31529475

2

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches

enthalten in: Headache | 2019

von Tepper, S. | Dodick, D. | Schmidt, P. | +1

3

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials : A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial

enthalten in: Headache | 2018

von Dodick, D. | Tepper, S. | Friedman, D. | +3

1
[1]